Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
1,177
+28
+2% +$6.02K 0.16% 94
2026
Q1
$230K Sell
1,149
-31
-3% -$6.88K 0.14% 101
2025
Q4
$261K Buy
1,180
+24
+2% +$5.47K 0.16% 88
2025
Q3
$283K Buy
+1,156
New +$235K 0.18% 78
2025
Q1
$225K Buy
+1,076
New +$209K 0.17% 90
2024
Q2
$214K Buy
+1,126
New +$187K 0.14% 99

Other funds holding ABBV

Members Wealth's ABBV Position: Q2 2026 in Review

Members Wealth increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $6.02K and bringing the position to 1,177 shares worth $296K. The position accounts for 0.16% of the portfolio, ranked #94.

Members Wealth first reported a position in ABBV in Q2 2024 and has held it in 6 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Members Wealth held 1,177 shares of AbbVie worth $296K as of Q2 2026.
  • Members Wealth bought 28 AbbVie shares in Q2 2026, an estimated $6.02K.
  • AbbVie made up 0.16% of Members Wealth's portfolio in Q2 2026, its #94 holding.
  • Members Wealth first reported a position in AbbVie in Q2 2024 and has held it in 6 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Members Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.